|
Origin | Propolis type/plant source | Type of extract/isolated compound(s) | Species/cells | Effect | References |
|
Purchased: Sigma Aldrich Co. Synthesized | Characteristic of European, Brazilian, and Mediterranean propolis | Caffeic acid, quercetin, naringenin; CAPE | Peritoneal macrophages | Suppression of lipoxygenase pathway of arachidonic acid metabolism CAPE being the most potent modulator of the arachidonic acid cascade | [90] |
|
Croatia | European propolis/Populus nigra | Water-soluble derivatives | Swiss albino mice | Reduction of DNA damage in peripheral lymphocytes | [188] |
PEE | Male Swiss albino mice | Suppression of functional activity of macrophages | [104] |
|
Purchased: Sigma Aldrich Co. | | | J774 macrophages, Male Wistar rats | In vitro and in vivo inhibition of cyclooxygenase 1 and cyclooxygenase 2 activity | [91, 189]; |
| | Male Wistar albino rats | Decrease of polymorphonuclear neutrophilic leukocyte infiltration in the lungs tissues | [190]; |
Characteristic of European type propolis | CAPE | Gastric epithelial cell line (AGS), H. pylori (strain NCTC 11638) | Inhibition of H. pylori-induced NF-kB and activator protein 1-DNA-binding activity; prevention of IkBα degradation in AGS; and suppression of TNF-α and interleukin 8 production | [191]; |
Purchased: Wako Pure Chemical Industries, Ltd. | | | RAW264.7 macrophages | Decrease of the production of interleukin-1β, monocyte chemoattractant protein 1, and the production and expression of tumor necrosis factor α (TNF-α) | [98]; |
| | Male Swiss inbred strain mice | Decrease of cyclooxygenase 2 expression, NF-κB activity, c-Jun-N-terminal kinase, inhibitor of NF-κB kinase (IKK), and inhibitor of NF-κB (IkB) phosphorylation | [97] |
|
Brazil | Green propolis/B. dracunculifolia | PEE | RAW264.7 macrophages | Downregulation of NF-κB, p38 mitogen-activated protein kinase, and c-Jun-N-terminal kinase |
[101] |
Purchased: Acros Organics | Characteristic of European, Brazilian, and Mediterranean propolis | Caffeic acid |
|
Brazil | Green propolis/B. dracunculifolia | PEE | Sprague-Dawley rats | Inhibition of carrageenan-induced rat hind paws edema and the chemotaxis of human polymorphonuclear leukocytes (PMNs) | [95] |
|
Synthesized | Characteristic of European type propolis | CAPE | Polymorphonuclear leukocytes obtained from Human blood | Inhibition of 5-lipoxygenase activity and arachidonic acid release | [103] |
|
Chile | European propolis/poplar trees | PEE | Male CF-1 mice | Inhibition of NO release by the macrophages | [102] |
|
China | European propolis/Populus nigra | PEE and PWE | Male ICR mice and male Wistar rats | Inhibition of the activation and differentiation of mononuclear macrophages; decrease prostaglandin-E2 (PGE 2) and nitric oxide (NO) levels | [61] |
|
Brazil | Green propolis/B. dracunculifolia | PWE | Swiss and BALB/c mice | Decrease in the number of macrophages and neutrophils; inhibition of proinflammatory cytokines and increase of anti-inflammatory cytokines | [99] |
Red propolis/Dalbergia ecastaphyllum | PEE | Male Wistar rats | Decrease in renal macrophage infiltration in rats with chronic kidney disease | [100] |
|
Nepal | Nepalese propolis/probably Shorea robusta, Dalbergia sissoo, Acacia catechu, and Bombax cieba | PEE, 3′,4′-dihydroxy-4-methoxydalbergione, 4-ethoxydalbergion, cearoin, and chrysin | Bone marrow-derived mast cells (BMMC) from C57BL/6 mice | Inhibiting IL-6, TNF-α, and IL-13 gene expression in BMMC and also inhibiting the activation of IKK leading to NF-κB inactivation | [96] |
|